Complete Substances Table
This table shows all prohibited substances with their complete normalized data. Use the filter inputs in each column header to filter the data. Click on column headers to sort by that field.
|
Name
|
Other Names
|
Classifications
|
DEA Schedule
|
Reason
|
Warnings
|
References
|
Added
|
Details
|
|---|---|---|---|---|---|---|---|---|
| 1-(1-phenylcyclohexyl)-pyrrolidine | PCPy, PHP, rolicyclidine, pyrrolidine analog of... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-(5-fluoropentyl)-3-(1-naphthoyl)indole | AM2201, AM-2201, AM2201 (1-(5-Fluoropentyl)-3-(... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole | AM-694, AM694 | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-[1-(2-thienyl)cyclohexyl]piperidine | TPCP, 1-[1-(2-thienyl)-cyclohexyl]-piperidine, ... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | TCPy | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole | JWH-200, JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-androstenediol | 3alpha,17beta-dihydroxy-5alpha-androst-1-ene, 3... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 1-androstenedione | 5ɑ-androst-1-ene-3ß, 17ß-dione, 5alpha-androst-... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 1-androsterone | 1-androstenolone, (3beta,5alpha)-3-hydroxyandro... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| 1-butyl-3-(1-naphthoyl)indole | JWH-073, JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-hexyl-3-(1-naphthoyl)indole | JWH-019, JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-(1-naphthoyl)indole | AM-678, AM678, JWH-018 (also known as AM678) (1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-(2-chlorophenylacetyl)indole | 2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)et... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-(2-methoxyphenylacetyl)indole | 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)e... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-(4-chloro-1-naphthoyl)indole | JWH-398, (4-chloronaphthalen-1-yl)(1-pentyl-1H-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-(4-methyl-1-naphthoyl)indole | (4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-y... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole | 1-pentyl-3-(4-methoxynaphthoyl)indole, JWH-081,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 1-phenylcyclohexylamine | 1-phenylcyclohexan-1-amine | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| 1-testosterone | Δ1-dihydrotestosterone, delta1-dihydrotestoster... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 11-keto-testosterone | 17β-Hydroxy-androst-4-en-3,11-one, 17beta-hydro... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| 11β-methyl-19-nortestosterone | 11beta-methyl-19-nortestosterone, 11beta-methyl... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| 13β-ethyl-17β-hydroxygon-4-en-3-one | 18-methyl-19-nortestosterone, 13beta-ethyl-17be... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17-dihydroexemestane | 17beta-dihydroxy exemestane, 17hydroxy 6methyle... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| 17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane | 17α-methyl-3α,17β-dihydroxy-5α-androstane | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane | 17-methyl-5α-androstane-3β,17β-diol, 17-methyl-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene | 17-methyl-androst-4-ene-3beta,17beta-diol, 17-m... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-4-hydroxynandrolone | 17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-e... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-5alpha-androstan-17beta-ol | protodrol, 17-methyl-5alpha-androstan-17beta-ol... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-androst-2-ene-3,17beta-diol | 17α-methyl-androst-2-ene-3,17β-diol, 17a-methyl... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-androsta-1,4-diene-3,17beta-diol | 17a-methyl-1,4-androstadiene-3,17diol, 17alpha-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17alpha-methyl-androstan-3-hydroxyimine-17beta-ol | 17α-methyl-androstan-3-hydroxyimine-17β-ol, 17a... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17beta-hydroxy-androstano[2,3-d]isoxazole | 17β-hydroxy-androstano[2,3-d]isoxazole, 17b-Hyd... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 17beta-hydroxy-androstano[3,2-c]isoxazole | 17β-hydroxy-androstano[3,2-c]isoxazole, 17b-Hyd... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one | N/A | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 19-nor-4,9(10)-androstadienedione | 19-norandrosta-4,9(10)-diene-3,17-dione, estra-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 19-nor-5-androstenediol | 3alpha,17beta-dihydroxyestr-5-ene, 3α, 17β-dihy... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 19-nor-5-androstenedione | 19-norandrost-5-en-3,17-dione, 19-norandrost-5-... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 19-norandrosterone | 19-nor-androsterone, 5alpha-estran-3alpha-ol-17... | 6000 | N/A | WADA S1: Anabolic agents; Unapproved ... | N/A | 1 refs | 2026-01-01 | View details |
| 2',5'-dimethoxyfentanyl | N-(1-(2,5- dimethoxyphenethyl)piperidine-4-yl)-... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 2,5-dimethoxyamphetamine | 2,5-dimethoxy-alpha-methylphenethylamine, 2,5-d... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one | 2-(3-dethoxyphenyl)-2-(N-ethylamino)cyclohexano... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2-androstenol | 5alpha-androst-2-en-17-ol, 5α-androst-2-en-17-ol | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| 2-androstenone | delta-2, 2-androstene-17-one, 5α-androst-2-en-1... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| 25B-NBOMe | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxyben... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 25C-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybe... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 25I-NBOMe | Cimbi-5, 2C-I-NBOMe, 2-(4-iodo-2,5-dimethoxyphe... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-C | 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine, 2-(... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-D | 2-(2,5-dimethoxy-4-methylphenyl) ethanamine, 2-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-E | 2,5-Dimethoxy-3,4-dimethylphenethylamine (2C-G)... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-H | 2-(2,5-dimethoxyphenyl)ethanamine, 2-(2,5-dimet... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-I | 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine, 2-(4-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-N | 2-(2,5-dimethoxy-4-nitro-phenyl) ethanamine, 2-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-P | 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-T-2 | 2-[4-(ethylthio)-2,5-dimethoxyphenyl] ethanamin... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-T-4 | 2,5-Dimethoxy-4-ethylthioamphetamine, 2-[4-(iso... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2C-T-7 | 2,5-dimethoxy-4(n)-propylthiophenethylamine, 2,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 2alpha,17alpha-dimethyl-17beta-hydroxy-5beta-androstan-3-one | 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one,... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 2′-fluoro ortho-fluorofentanyl | 2'-Fluoro ortho-fluorofentanyl (N-(1-(2- fluoro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3,4-dimethylmethcathinone | 3,4-DMMC | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3-MMC | 2-(methylamino)-1-(3-methylphenyl)propan-1-one | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 3-androstenol | 5α-androst-3-en-17-ol, 5alpha-androst-3-en-17-o... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| 3-androstenone | 5α-androst-3-en-17-one, 5alpha-androst-3-en-17-... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| 3-fluoro-N-methylcathinone | 3-FMC, 1-(3-fluorophenyl)-2-(methylamino)propan... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3-furanyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-c... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 3-methylethcathinone | 3-MEC | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3-methylfentanyl | 3-MF, mefentanyl, China White, N-[3-methyl-1-(2... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3-methylthiofentanyl | N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 3beta-hydroxy-estra-4,9,11-trien-17-one | 3β-hydroxy-estra-4,9,11-trien-17-one, 3b-hydrox... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 4'-chloro-alpha-PVP | 4'-chloro-α-pyrrolidinopentiophenone, 4-chloro-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4,4′-Dimethylaminorex | 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazo... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2- F][1,2,4]triazolo[4,3-A][1,4]diazepine | etizolam | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-MEAP | 4-methyl-alpha-ethylaminopentiophenone, 4-methy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-MePPP | 4-methyl-alphapyrrolidinopropiophenone, 1-(4-me... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-OH-DiPT | 4-hydroxy-N,N-diisopropyltryptamine | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| 4-androstene-3,6,17 trione | 6-oxo-androstenedione, androst-4-ene-3,6,17-tri... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| 4-androstenediol | androst-4-ene-3β,17β-diol, 3β,17β-dihydroxy-and... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 4-anilino-N-phenethylpiperidine | 4-anilino-N-phenethyl-4-piperidine, N-phenyl-1-... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| 4-bromo-2,5-dimethoxyphenethylamine | alpha-desmethyl DOB, Nexus, 2C-B, 2-(4-bromo-2,... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 4-fluoro-N-methylcathinone | 1-(4-fluorophenyl)-2-(methylamino)propan-1-one)... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-fluoroisobutyryl fentanyl | p-fluoroisobutyrfentanyl, N-(4-fluorophenyl)-N-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-fluoromethylphenidate | (±)-threo-4-fluoromethylphenidate, 4-FMPH, 4F-MPH | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| 4-hydroxytestosterone | 4,17β-dihydroxyandrost-4-en-3-one, 4-hydroxytes... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 4-methoxyamphetamine | 4-methoxy-α-methylphenethylamine, PMA, p-methox... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-methyl-N-ethylcathinone | 4-MEC, 2-(ethylamino)-1-(4-methylphenyl)-1-prop... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-methylaminorex, cis-(+/-)- | U4Euh, 4-methylaminorex (cis isomer), (±)cis-4,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4-methylamphetamine | 4-MA, p-methylamphetamine, p-methylamfetamine | 6000 | N/A | Controlled substance: Schedule II | N/A | 1 refs | 2026-01-01 | View details |
| 4-methylbuphedrone | 4-MeMABP, 4-MeBP | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4F-MDMB-BINACA | methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carbo... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 4F-MDMB-BUTICA | 4fluoro-MDMB-BUTICA, methyl 2-[[1-(4-fluorobuty... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 4′-methyl acetyl fentanyl | N-(1-(4-methylphenethyl)piperidin-4-yl)-N-pheny... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol | CP-47,497 | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol | CP-47,497 C8-homolog, cannabicyclohexanol | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-MeO-AMT | 5-methoxy-alpha-methyltryptamine | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| 5-MeO-DET | 5-methoxy-N,N-diethyltryptamine | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| 5-MeO-DIPT | Foxy methoxy, FOXY, 5-methoxy-N,N-dipropyltrypt... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-MeO-DMT | methylbufotenine, 5-methoxy-N,N-dimethyltryptam... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-MeO-MiPT | 5-methoxy-N-methyl-N-isopropyltryptamine | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| 5-alpha-hydroxy-laxogenin | Biobras 16, BB-16, spirostan-6-one, 3,5-dihydro... | 6000 | N/A | FDA Warning Letter: Does not meet the... | N/A | 1 refs | 2026-01-01 | View details |
| 5-androstenedione | androst-5-en-3,17-dione, androst-5-ene-3,17-dio... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 5-fluoro-PB-22 | 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid ... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5-fluoro-UR-144 | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tet... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-AB-PINACA | 5-fluoro-AB-PINACA, N-(1-amino-3-methyl-1-oxobu... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-ADB | 5F-EMB-PINACA, methyl 2-(1-(5-fluoropentyl)-1H-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-AMB | methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carb... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-APINACA | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazo... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 5F-CUMYL-P7AICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-p... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-CUMYL-PINACA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-i... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-EDMB-PICA | 5fluoro-EDMB-PICA, ethyl 2-[[1-(5-fluoropentyl)... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 5F-EDMB-PINACA | ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carbo... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5F-MDMB-PICA | 5-fluoro-EMB-PICA, 5F-MDMB-2201, 5FMDMB-PICA, 5... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 5alpha-androstan-3,6,17-trione | 5alpha-androstane-3,6,17-trione, 5α-androstane-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine | clonazolam | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 6-bromo-androsta-1,4-diene-3,17-dione | 6-bromoandrosta-1,4-diene-3,17-dione, 6-bromo b... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 6-bromo-androstan-3,17-dione | N/A | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| 6-monoacetylmorphine | 6-MAM | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| 6alpha-methyl-androst-4-ene-3,17-dione | 6α-methylandrostenedione, 6alpha-methylandroste... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro- 2H-benzo[E][1,4]diazepin-2-one | diclazepam | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 7-isopropoxyisoflavone | 7-isopropoxy-3-phenyl-4H-chromen-4-one, Iprifla... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| 7-keto DHEA | 7-keto-DHEA, 3beta-hydroxyandrost-5-ene-7,17-di... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| 7alpha-hydroxy-DHEA | 7α-OH-DHEA, 7alpha-hydroxydehydroepiandrosteron... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| 7beta-hydroxy-DHEA | 7b-hydroxydehydroepiandrosterone, 7β-hydroxy-DHEA | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]trazolo[4,3-A][1,4]diazepine | flubromazolam | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine | flualprazolam | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| 9-hydroxyfluorene | 9-fluorenol, hydrafinil, fluoren-9-ol, 9 fluore... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| AB-CHMINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohe... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluor... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| AB-PINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| AC-262536 | AC-262,536, 4-(3-endo-hydroxy-8-azabicyclo(3.2.... | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 2 refs | 2026-01-01 | View details |
| ACE-031 | Ramatercept | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| ACP-105 | 2-chloro-4-[(1R,5S)-3-hydroxy-3-methyl-8-azabic... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| ADB-4en-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pen... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| ADB-BUTINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-buty... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-f... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pent... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| AH-7921 | 3,4-dichloro-N-[(1-dimethylamino)cyclohexylmeth... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| AICAR | AICAriboside 5'-monophosphate, NSC 292227, 5'-p... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| AMB-FUBINACA | methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carb... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| AOD-9604 | AOD 9604 | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| APINACA | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxam... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| Acacia rigidula | Chaparro prieto, Acaciopsis rigidula, blackbrus... | 6000 | N/A | FDA statement: New dietary ingredient... | N/A | 1 refs | 2026-01-01 | View details |
| Aconitum | aconite root, queen of poisons, mousebane, leop... | 6000 | N/A | Potentially fatal poisonous plant | N/A | 1 refs | 2026-01-01 | View details |
| Amanita muscaria | fly agaric mushroom, ibotenic acid, muscarine, ... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| Areca catechu nut | areca nut, betel nut, Areca catechu extract, ar... | 6000 | N/A | Per DoDI 1010.04 and DoDI 6130.06 | N/A | 1 refs | 2026-01-01 | View details |
| BMPEA | beta-phenylpropylamine, B-Methylphenethylamine,... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 1 refs | 2026-01-01 | View details |
| BMS-564929 | BMS-564,929, benzonitrile, 2-chloro-3-methyl-4-... | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 2 refs | 2026-01-01 | View details |
| BPC-157 | Bepecin, PL-14736, body protection compound | 6000 | N/A | WADA S0: Non-approved Substances; Una... | N/A | 1 refs | 2026-01-01 | View details |
| CJC-1293 | N/A | 6000 | N/A | WADA S2: Hormones; Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| CJC-1295 | DAC-GRF | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| CNTO-530 | N/A | 6000 | N/A | WADA S2: Hormones (EPO mimetic); Unap... | N/A | No refs | 2026-01-01 | View details |
| CP-47,497 | 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycycl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| CUMYL-4CN-BINACA | 4-cyano-CUMYL-BUTINACA, 1-(4-cyanobutyl)-N-(2-p... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| CUMYL-PEGACLONE | 5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-B]in... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| Catha edulis | khat, Abyssinian tea, Graba | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| DMAA (1,3) | 1,3-DMAA, dimethylpentylamine, Floradrene, 1,3-... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 1 refs | 2026-01-01 | View details |
| DMAA (1,4) | 5-methyl-2-hexylamine, 5-methylhexan-2-amine, 1... | 6000 | N/A | N/A | N/A | 2 refs | 2026-01-01 | View details |
| DMBA | 1,3-DMBA, 1,3-dimethylbutanamine, 4-methyl-2-pe... | 6000 | N/A | FDA statement: New dietary ingredient... | N/A | 1 refs | 2026-01-01 | View details |
| DMHA | Vaporpac, 1,5-DMHA, 2-isooctyl amine, 2-aminois... | 6000 | N/A | FDA statement: New dietary ingredient... | N/A | 1 refs | 2026-01-01 | View details |
| DOB | 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-DMA | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| DOC | 2,5-dimethoxy-4-chloroamphetamine | 6000 | N/A | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| DOET | 2,5-dimethoxy-4-ethylamphetamine, 2,5-dimethoxy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| DOI | 2,5-dimethoxy-4-iodoamphetamine | 6000 | N/A | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| DOM | STP, 4-methyl-2,5-dimethoxy-α-methylphenethylam... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| Desidustat | ZYAN1 | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| DiPT | N,N-diisopropyltryptamine | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| Enarodustat | JTZ-951 | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| FG-2216 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| FP-3 | Pentobarbital & noncontrolled active ingred | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| FUB-144 | [1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl](2,2,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| FUB-APINACA | AKB48 N-(4-FLUOROBENZYL), FUB-AKB48, N-(adamant... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| GHRP-1 | growth hormone-releasing peptide 1 | 6000 | N/A | WADA S2: HormonesUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| GHRP-6 | hexapeptide-2, growth hormone-releasing peptide... | 6000 | N/A | WADA S2: HormonesUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| GSK2881078 | SARM GSK2881078 | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| GW-0742 | GW 0742X, GW610742, {4-[({2-[3-fluoro-4-(triflu... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| GW-501516 | GSK-516, GW501516, 2-[2-methyl-4-[[4-methyl-2-[... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | No refs | 2026-01-01 | View details |
| HCG | chorionic gonadotropin, hCG, human chorionic go... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| HGH | Humatrope, somatotropin recombinant, Accretropi... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| IGF | recombinant human insulin-like growth factor-1,... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| IOX2 | JICL38 | 6000 | N/A | WADA S2: HormonesUnapproved drug | N/A | No refs | 2026-01-01 | View details |
| IOX4 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| JNJ-28330835 | (3 S)-3-methyl-5-trifluoromethyl-3,4-dihydro-2H... | 6000 | N/A | WADA S1: AnabolicUnapproved drugFDA s... | N/A | 2 refs | 2026-01-01 | View details |
| JNJ-42041935 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| K-11706 | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | No refs | 2026-01-01 | View details |
| LGD-2226 | LGD2226, 6-(bis-(2,2,2-trifluoroethyl)amino)-4-... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| LGD-3303 | LGD 3033, LGD3033, LGD-3033, 7H-pyrrolo(3,2-F)q... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| LGD-4033 | VK5211, anabolicum, LGD4033, VK-5211, 4-((R)-2-... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| MAB-CHMINACA | ADB-CHMINACA, N-(1-amino-3,3-dimethyl-1-oxobuta... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDA | N-hydroxy-3,4-methylenedioxyamphetamine, Love D... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDEA | MDMB, 3,4-methylenedioxy-N-ethylamphetamine, MD... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDMA | Ectasy, 3,4-methylenedioxymethamphetamine, XTC,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDMB-4en-PINACA | methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-in... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| MDMB-CHMICA | methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carb... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDMB-FUBINACA | methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carb... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MDPV | 3,4-methylenedioxypyrovalerone, 1-(1,3-benzodio... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MK-677 | MK 0677, Nutrobal, 2-amino-N-((R)-2-(benzyloxy)... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| MMB-CHMICA | methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carb... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MMB-FUBICA | methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carbox... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| MMDA | 5-methoxy-3,4-methylenedioxy-amphetamine, 5-met... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MPHP | 4'-methyl-alpha-pyrrolidinohexiophenone, 1-(4-m... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MPPP | 1-methyl-4-phenyl-4-propionoxypiperidine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N,N-dimethylamphetamine | N,N-alpha-trimethylphenethylamine, dimethylamph... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N,N-dimethylethylamine | 1,3-dimethylethylamine, dimethylethylamine, DME... | 6000 | N/A | Industrial chemical | N/A | 1 refs | 2026-01-01 | View details |
| N-benzylpiperazine | 1-benzylpiperazine tartrate, 1-benzylpiperazine... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethyl-1-phenylcyclohexylamine | PCE, (1-phenylcyclohexyl)ethylamine, cyclohexam... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethyl-3-piperidyl benzilate | JB 323 | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethyl-N-methylcathinone | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethylamphetamine | ethylamphetamine, etilamfetamine, NEA, Adiparth... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethylbuphedrone | NEB | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethylhexedrone | 2-(ethylamino)-1-phenylhexan-1-one | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-ethylpentylone | βk-ethyl-K, β-keto-ethylbenzodioxolylpentanamin... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-methyl-3-piperidyl benzilate | JB 336 | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| N-methyltyramine | p-(2-(Methylamino)ethyl)phenol, methyl tyramine... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| N-pyrrolidino etonitazene | (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| NM2201 | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| Nymphaea caerulea | blue lotus, blue lotus (Nymphaea caerulea), Egy... | 6000 | N/A | Per DoDI 1010.04 and DoDI 6130.06 | N/A | 1 refs | 2026-01-01 | View details |
| PCC | 1-piperidinocyclohexanecarbonitrile | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| PEPAP | 1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| PV8 | alpha-pyrrolidinoheptaphenone, 1-phenyl-2-(pyrr... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| Piper methysticum | kava kava, kava, kavain, kawain, kavalactone, k... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| QUPIC | PB-22, quinolin-8-yl 1-pentyl-1H-indole-3-carbo... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| R3-IGF-1 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| RAD-150 | teptadrol, (2S,3R)-3-[(4-cyanophenyl)-1,3,4- ox... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| S-107 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| S-23 | (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-f... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| S-40503 | 2-(4-(dimethylamino)-6-nitro-1,2,3,4-tetrahydro... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| S48168 (ARM210) | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| S519 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| S597 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| SARM | selective androgen receptor modulator, SARMs | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 1 refs | 2026-01-01 | View details |
| SARM S1 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| SARM S9 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| SR-18 | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indo... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| SR-19 | RCS-4, 1-pentyl-3-[(4-methoxy)-benzoyl]indole, ... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| SR-9009 | Stenabolic, SR9009, ethyl 3-[[(4-chlorophenyl)m... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| SR-9011 | 1-pyrrolidinecarboxamide, 3-((((4-chlorophenyl)... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| Salvia divinorum | Divine Mexican Mint, Pipiltzintzintli, divinori... | 6000 | N/A | Military policy | N/A | 1 refs | 2026-01-01 | View details |
| TB-500 | Ac-LKKTETQ | 6000 | N/A | WADA S2: Peptide Hormones - Growth Fa... | N/A | 1 refs | 2026-01-01 | View details |
| THJ-2201 | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| TMA | 3,4,5-trimethoxyamphetamine, 3,4,5-trimethoxy a... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| U-47700 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyc... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| YK-11 | YK-11-OA, 19-norpregna-4,20-diene-21-carboxylic... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| [3,2-c]-furazan-5alpha-androstan-17beta-ol | [3,2-c]-furazan-5α-androstan-17β-ol | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| [3,2-c]pyrazole-androst-4-en-17beta-ol | [3,2-c]pyrazole-androst-4-en-17β-ol | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| acetazolamide | acetazolamide sodium | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| acetorphine | 7alpha-etorphine 3-acetate | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| acetyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| acetyl-alpha-methylfentanyl | acetyl-α-methylfentanyl, alphamethylacetylfenta... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| acetyldihydrocodeine | dihydrothebacone, dihydrocodeine 6-acetate | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| acetylmethadol | acemethadone, methadyl acetate | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| acetylpsilocin | O-acetylpsilocin , 4-AcO-DMT, psilacetin, 4-ace... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| aconitine | acetylbenzoylaconine | 6000 | N/A | Unapproved drug; Extract of a poisono... | N/A | 1 refs | 2026-01-01 | View details |
| acryl fentanyl | acryloylfentanyl, acrylfentanyl, N-(1-phenethyl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| adamantoyl | 1-pentyl-3-(1-adamantoyle)indole, AB-001 | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | 1 refs | 2026-01-01 | View details |
| adrafinil | 2-((diphenylmethyl)sulfinyl)-N-hydroxyacetamide... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| adrenosterone | androst-4-ene-3,11,17-trione, 11-oxoandrostened... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| aegeline | aegelin, N-2-hydroxy-2(4-methoxyphenyl) ethyl-3... | 6000 | N/A | FDA warning letter: New dietary ingre... | N/A | 2 refs | 2026-01-01 | View details |
| alexamorelin | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | No refs | 2026-01-01 | View details |
| alfaxalone | 5alpha-pregnan-3alpha-ol-11,20-dione, Alfaxan | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| alfentanil | alfentanyl, Alfenta, N-(1-(2-(4-ethyl-5-oxo-2-t... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| allylprodine | alperidine, 4-piperidinol, 1-methyl-4-phenyl-3-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha'-methyl butyryl fentanyl | 2-methyl-N-(1phenethylpiperidin-4-yl)-N-phenyl... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| alpha-PHP | alpha-pyrrolidinohexiophenone, α-PHP, alpha-pyr... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-PiHP | 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-o... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| alpha-ethyltryptamine | ET, etryptamine, Trip, α-ethyltryptamine, Monas... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-methylfentanyl | N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-methylthiofentanyl | N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-methyltryptamine | 3-(2-aminopropyl)indole, AMT, N-methyltryptamin... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-pyrrolidinobutiophenone | alpha-PBP, α-PBP, 1-phenyl-2-(pyrrolidin-1-yl)b... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alpha-pyrrolidinopentiophenone | flakka, α-pyrrolidinovalerophenone, 1-phenyl-2-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alphacetylmethadol | alphacemethadone, alpha-3-acetoxy-6-dimethylami... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alphameprodine | 3alpha-ethyl-1-methyl-4-phenyl-4alpha-piperidyl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alphamethadol | alpha-methadol | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| alphaprodine | prodine, 1,3-dimethyl-4-phenyl-4-propionoxypipe... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| alprazolam | α-hydroxy-alprazolam, Xanax | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| amfetaminil | amphetaminil, AN-1, N-cyanobenzylamphetamine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | 1 refs | 2026-01-01 | View details |
| amiloride | Midamor | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| amineptine | (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| aminoglutethimide | 3-(4-Aminophenyl)-3-ethylpiperidine-2,6-dione, ... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| aminorex | 4,5-dihydro-5-phenly-2-oxazolamine, aminoxaphen... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| amiphenazole | Phenamizol, Phenamizole, amiphenazole monohydro... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| amobarbital | Amobarbital & noncontrolled active ingred., iso... | 6000 | Schedule I | Controlled substance: Schedule II & III | N/A | No refs | 2026-01-01 | View details |
| amphetamine | 1-methyl-2-phenylethylamine, Obetrol, desoxynor... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| anamorelin | 3-piperidinecarboxylic acid, 1-(2-methylalanyl-... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| anastrozole | Arimidex, 2-[3-(2-Vyanopropan-2-yl)-5-(1,2,4-tr... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 2 refs | 2026-01-01 | View details |
| andarine | (2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-... | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 2 refs | 2026-01-01 | View details |
| androsta-3,5-diene-7,17-dione | arimistane, 3-deoxy-7-oxo-DHEA, androst 3,5-die... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| androstadienone | 4,16-androstadien-3-one, androsta-4,16-dien-3-o... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| androstanediol | 3α,17β-dihydroxy-5α-androstane, 3alpha-androsta... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| androstanedione | 5α-androstan-3,17-dione, 5α-androstane-3,17-dio... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| androstanolone | dihydrotestosterone, stanolone, 5α-dihydrotesto... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| androstatrienedione | ATD, androst-1,4,6-triene-3,17-dione, 1,4,6-eti... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| androstenediol | 3beta,17beta-dihydroxy-androst-5-ene, 5-androst... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| androstenedione | androst-4-en-3,17-dione, 17-ketotestosterone, 4... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| androsterone | 3a-hydroxy-5a-androstan-17-one, 3α-hydroxyetioa... | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 1 refs | 2026-01-01 | View details |
| anileridine | Leritine, Alidine, Nipecotan, Adopol, ethyl 1-[... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| aniracetam | Draganon, 1-(4-methoxybenzoyl)-2-pyrrolidinone,... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| apitegromab | N/A | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| aprobarbital | Alurate | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| arformoterol | formoterol R,R-form | 6000 | N/A | WADA S3: Beta-2 Agonists; Prescriptio... | N/A | 2 refs | 2026-01-01 | View details |
| asialo EPO | asialo-erythropoietin, ASIALO-EPO, asialo eryth... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | No refs | 2026-01-01 | View details |
| barbital | Plexonal, barbitone, Veronal, 5,5-diethylbarbit... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| barbituric acid | Malonylurea, barbituric acid derivative, 6-hydr... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| bazedoxifene | WAY 140424, TSE424, bazedoxifene acetate, Conbr... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 2 refs | 2026-01-01 | View details |
| bendroflumethiazide | Aprinox, bendrofluazide, Naturetin | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| benfluorex | benfluramate, Mediator, benfluorex hydrochlorid... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| benzethidine | ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| benzimidazole | 1,3-benzodiazole, 1H-benzimidazole | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| benzoylecgonine | 3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octa... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| benzphetamine | Didrex, benzfetamine, (R,S)-N-benzyl-alpha,N-di... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| benzylmorphine | 3-benzyloxy-4,5alpha-epoxy-17-methyl-7-morphine... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| beta'-phenyl fentanyl | β′-phenyl fentanyl, beta'-phenyl fentanyl, N-(1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| beta-hydroxy-3-methylfentanyl | N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piper... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| beta-hydroxyfentanyl | N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-p... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| beta-hydroxythiofentanyl | N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidi... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| beta-methyl fentanyl | β-methyl fentanyl , N-phenyl-N-(1-(2-phenylprop... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| betacetylmethadol | (3S,6R)-3-acetoxy-6-dimethylamino-4,4-diphenylh... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| betameprodine | NU-1932 | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| betamethadol | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| betaprodine | beta-1,3-dimethyl-4-phenyl-4-propionyloxypiperi... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| bezitramide | Burgodin | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| bimagrumab | human anti-ACTRIIB monoclonal antibody | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| bismuth nitrate | bismuth(III) nitrate pentahydrate, bismuth trin... | 6000 | N/A | OTC drug | N/A | 1 refs | 2026-01-01 | View details |
| bolasterone | 7α,17α-dimethyltestosterone, 7α,17α-dimethyl-17... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| boldenone | 1,4-androstadiene-17-beta-ol-3-one, Equigan, Ul... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| boldione | androsta-1,4-diene-3,17-dione, androstadienedio... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| brexanolone | allopregnan-3alpha-ol-20-one, allopregnanolone,... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| brivaracetam | UCB-34714, BRV, Briviact, (2S)-2-[(4R)-2-oxo-4-... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| brolamfetamine | 4-bromo-2,5-DMA, 4-bromo-2,5-dimethoxy-amphetam... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| bromantan | N-(2-adamantyl)-N-(4-bromophenyl)amine, bromont... | 6000 | N/A | Unapproved drug | N/A | 2 refs | 2026-01-01 | View details |
| bromazepam | 7-bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| brorphine | 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| bufotenine | 3-(2-dimethylaminoethyl)-5-indolol, N, N-dimeth... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| bumetanide | Bumex | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| buprenorphine | Buprenex, Temgesic, Subutex, Suboxone | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| buserelin | tiloryth | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| butabarbital | Butisol, secbutabarbital, Butibel | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| butalbital | Fiorinal, butalbital with aspirin | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| butobarbital | Soneryl, butethal | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| butonitazene | (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| butorphanol | (-)-17-(cyclobutylmethyl)morphinan-3,14-diol, S... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| butylone | MDDMC, bk-MDDMA, N,N-dimethyl-3,4-methylenediox... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| butyryl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamid... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| calusterone | Mesosarb, 7beta,17alpha-dimethyl-17betahydroxya... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| camazepam | Limpidon, Paxor, Albego | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| cannabidiol | CBD, Epidiolex, 1,3-benzenediol, 2-(3-methyl-6-... | 6000 | N/A | Military policy | N/A | 1 refs | 2026-01-01 | View details |
| cannabigerol | cannabigerol (CBG), Cannabis Extract 5% CBG, CBG | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| cannabis | Cannabis sativa L., Cannabis sativa | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| canrenone | Aldadiene | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| capromorelin | CP-424,391 | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| carbamylated EPO | cEPO | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | No refs | 2026-01-01 | View details |
| carbazole | dibenzopyrrole, 9h-carbazole | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| carfentanil | Wildnil | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| carisoprodol | Soma | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| cathine | d-norpseudoephedrine, Fasupond, norpseudoephedr... | 6000 | Schedule I | Controlled substance: Schedules III a... | N/A | No refs | 2026-01-01 | View details |
| cathinone | alpha-aminopropiophenone, 2-aminopropiophenone,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| cenobamate | carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| cesium chloride | cesium salt, CsCl, caesium chloride | 6000 | N/A | FDA statement: New dietary ingredient... | N/A | 1 refs | 2026-01-01 | View details |
| chloral betaine | Beta Chlor | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| chloral hydrate | Noctec | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| chlordiazepoxide | Libritabs, Librium, SK-Lygen, Limbitrol | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| chlorhexadol | Medodorm, Mecoral, Mechloral, Chloralodol | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| chlorodehydromethylandrostenediol | (3beta,17beta)-4-chloro-17-methyl-androsta-1,4-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| chloromethylandrostenediol | 4-chloro-17-methyl-androst-4-ene-3,17-diol, Pro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| chlorothiazide | Diuril | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| chlorphentermine | Desopimon, Apsedon, Pre-Sate, Lucofen | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| chlorthalidone | chlortalidone | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| clenbuterol | Clen | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 1 refs | 2026-01-01 | View details |
| clobazam | Urbanyl, Urbadan | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| clobenzorex | benzeneethanamine, N-((2-chlorophenyl)methyl)-α... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | 1 refs | 2026-01-01 | View details |
| clomifene | clomid, clomifen, clomiphene citrate, chloramip... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 2 refs | 2026-01-01 | View details |
| clonazepam | klonopin, clonopin | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| clonitazene | benzimidazole, 2-(p-chlorobenzyl)-1-(2-(diethyl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| clorazepate | Tranxene | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| clortermine | Voranil | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| clostebol | clostebol acetate, 4-chloro-delta-4-androstene-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| clotiazepam | Trecalmo, Rize, Veratran, Clozan | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| cloxazolam | Akton, Olcadil, Luballix, Sepazon | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| cobalt | cobalt chloride | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| cocaine | coca leaves, methyl benzoylecgonine, Crack | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| cocaine metabolites | N/A | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| codeine | morphine methyl ester, methyl morphine | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| codeine methylbromide | codeine bromomethylate, Eucodin, codeine methyl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| codeine-N-oxide | codeine N-oxide | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| coluracetam | N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-B)qu... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| conivaptan | N/A | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| corticorelin | corticorelin acetate | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| cropropamide | 2-[[(E)-but-2-enoyl]-propylamino]-N,N-dimethylb... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| crotetamide | crotetamida, crotetamidum, crotethamide | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| crotonyl fentanyl | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| cyanostane | 2-cyano-17a-methyl-17b-hydroxy-androstan-3-one,... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| cyclofenil | 4,4'-(cyclohexylidenmethylen)diphenyl diacetat,... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| cyclopentyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopent... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| cyclopropyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylcycloprop... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| cyprenorphine | N-Cyclopropylmethyl-6,14-endoetheno-7alpha-(1-h... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| cyproheptadine | Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-yli... | 6000 | N/A | Prescription drug | N/A | 1 refs | 2026-01-01 | View details |
| danazol | Danocrine, [1,2]oxazolo[4',5':2,3]pregna-4-en-2... | 6000 | N/A | WADA S1: Anabolic Agents; Prescriptio... | N/A | 2 refs | 2026-01-01 | View details |
| daprodustat | GSK1278863 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| darbepoetin alfa | Aranesp, darbepoetin | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 2 refs | 2026-01-01 | View details |
| daridorexant | methanone, ((2S)-2-(6-chloro-7-methyl-1H-benzim... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| dehydrochlormethyltestosterone | 4-chloro-17betahydroxy-17alpha-methylandrost-1... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| dehydroepiandrosterone | Psicosterone, androstenolone, GL-701, 3β-hydrox... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| delorazepam | chlordesmethyldiazepam, nordiclazepam | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| demelverine | N-methyl-β,β′-diphenyldiethylamine, methpheneth... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| des(1-3)IGF-1 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| deslorelin | D-TRP-LHRH-PEA | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| desmopressin | Stimate, Nocdurna, DDAVP | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| desomorphine | 6-deoxy-7,8-dihydromorphine, dihydrodesoxymorph... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| desoxymethyltestosterone | 17alpha-methyl-5alpha-androst-2-en-17beta-ol, m... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| desoxytestosterone | 5α-androst-2-en-17β-ol, 5α-androst-3-en-17β-ol | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| dexfenfluramine | Redux | 6000 | N/A | Controlled substance: Schedule IV | N/A | 1 refs | 2026-01-01 | View details |
| dextromoramide | Jetrium, Palfium, Narcolo | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dextropropoxyphene | propoxyphene, Darvon, alpha-(+)-4-dimethylamino... | 6000 | Schedule I | Controlled substance: Schedule IV in ... | N/A | No refs | 2026-01-01 | View details |
| diampromide | N-[2-(methylphenethylamino)propyl]propionanilid... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| diazepam | Valium, Diastat | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| dichloralphenazone | dichloralantipyrine, Midrin | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| dienolone | estra-4,9-dien-17b-ol-3-one, 17β-Hydroxy-estra-... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| diethylpropion | diethylpropione, Danylen, amfepramon, amphepram... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| diethylthiambutene | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| diethyltryptamine | DET, MiPT, N,N-diethyltryptamine, N-methyl-N-is... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| difenoxin | Lyspafen, Motofen | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dihexa | PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic ... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| dihydrocodeine | Parzone, Didrate | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| dihydroetorphine | tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,1... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| dihydromorphine | 7,8 dihydromorphine, Paramorphan, 6-alpha-hydro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dimenoxadol | Lokarin, 2-(dimethylamino)ethyl ethoxydiphenyla... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dimepheptanol | methadol, racemethadol | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dimethandrolone | 7alpha,11beta-dimethyl-19-nortestosterone, 7α,1... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| dimethoxymethamphetamine | 3,4-dimethoxymethamphetamine, DMMA | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| dimethylthiambutene | dimethibutin, aminobutene, 3-dimethylamino-1,1-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dimethyltrienolone | 17β-Hydroxy-7α,17α-dimethyl-estra-4,9,11-trien-... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| dimethyltryptamine | DMT, N,N-dimethyltryptamine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| dinitrophenol | 2.4-dinitrophenol, 2,4-dinitrophenol, 2,4-DNP, ... | 6000 | N/A | WADA S0: Non-approved Substances; Una... | N/A | 1 refs | 2026-01-01 | View details |
| dioxaphetyl butyrate | ethyl 4-morpholino-2,2-diphenylbutyrate, 4-morp... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| diphenoxylate | N/A | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| dipipanone | phenylpiperone HCl, Wellconal, Dipipan, Diconal | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| domagrozumab | PF-06252616 | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| dronabinol | (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimeth... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| drostanolone | 2(α)-methyldihydrotestosterone, Masterone, Drol... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| drotebanol | oxymethebanol, Metabanyl | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ecgonine | cocaine precursor | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| ecgonine methyl ester | EME, methylecgonine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| elacestrant | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| eluxadoline | VIBERZI, 5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| embutramide | Tributane | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| enobosarm | GTx 024, MK-2866 ester, MK-2866, MK2866 acetate... | 6000 | N/A | WADA S1: Anabolic Agents; Unapproved ... | N/A | 2 refs | 2026-01-01 | View details |
| ephedra | epitonin, Sida cordifolia Linn, Ephedra interme... | 6000 | N/A | Federal regulation passed specificall... | N/A | 1 refs | 2026-01-01 | View details |
| ephedrine alkaloids | norephedrine, ephedrine, ephedra alkaloids, N-p... | 6000 | N/A | Federal regulation passed specificall... | N/A | 1 refs | 2026-01-01 | View details |
| epi-dihydrotestosterone | 5β-DHT, 17-hydroxyandrostan-3-one, epi-DHT, 5be... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| epiandrosterone | 5α-androstan-3β-ol-17-one, isoandrosterone, epi... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | No refs | 2026-01-01 | View details |
| epistane | hemapolin, havoc, 2alpha,3alpha-epithio-17alpha... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| epitalon | N/A | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| epitestosterone | cis-testosterone, 17-epitestosterone, 17alpha-t... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| epitrenbolone | alpha-trenbolone, estra-4,9,11-trien-3-one, 17-... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| epthiostane | 17β-hydroxy-2α,3α-epithio-5α-androstane | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| erythropoietin | human erythropoietin, Epogen, epoetin theta, ep... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 2 refs | 2026-01-01 | View details |
| erythropoietin Fc | EPO-Fc | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| estazolam | Eurodin, Domnamid, Nuctalon, ProSom | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| estra-4,9,11-triene-3,17-dione | trendione, trenavar | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| etamivan | Cardiovanil, Corivanil, Sevanil, Diethamivan, E... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| ethacrynic acid | etacrynic acid, sodium ethacrynate, ethacrinic ... | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 2 refs | 2026-01-01 | View details |
| ethchlorvynol | Placidyl | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| ethinamate | Valmid, Valamin | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| ethyl loflazepate | Meilax, Ronlax, Victan, ethyl 7-chloro-2,3-dihy... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| ethylestrenol | Maxibolin, Orabolin, 17alpha-ethyl-17beta-hydro... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| ethylmethylthiambutene | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ethylmorphine | Dionin | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| ethylone | MDEC, 3,4-methylenedioxy-N-ethylcathinone, bk-M... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ethylphenidate | EPH, ethylphenidate, threo- | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| etilefrine | etilefrina, Eti-Puren, Effortil, etilefrin, eth... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| etiocholanolone | 5-isoandrosterone, 3alpha-hydroxy-5beta-androst... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| etodesnitazene | Etazone, benzimidazole, 1-(2-(diethylamino)ethy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| etonitazene | Chinese Dwarf, 1-(2-(diethylamino)ethyl)-2-(p-e... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| etorphine | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| etorphine hydrochloride | M 99, etorphine HCl | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| etoxeridine | Wy-2039, Carbetidine, Atenos, isonipecotic acid... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| eutylone | 1-(1,3-benzodioxol-5-yl)-2(ethylamino)butan-1-one | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| examorelin | hexarelin | 6000 | N/A | WADA S2: HormonesUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| exemestane | androsta-1,4-diene-3,17-dione, 6-methylene-, PN... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 2 refs | 2026-01-01 | View details |
| ezogabine | Potiga, N-[2-amino-4-(4-fluorobenzylamino)-phen... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| famprofazone | famprofazone hydrochloride, 4-isopropyl-2-methy... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| fenbutrazate | phenbutrazate, fenbutrazatum, phenbutrazatum, f... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| fencamfamin | Reactivan | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| fencamine | Sicoclor, 1,3,7-trimethyl-8-[2-[methyl(1-phenyl... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| fenethylline | amfetyline, ethyltheophylline amphetamine, fene... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| fenoterol | (1RS)-1-(3,5-dihydroxyphenyl)-2-(((1RS)-2-(4-hy... | 6000 | N/A | WADA S3: Beta-2 AgonistsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| fenproporex | Solvolip, Gacilin | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| fentanyl | Actiq, Innovar, Duragesic, Oralet, Sublimaze | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| fentanyl carbamate | ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| fludiazepam | N/A | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| flunitazene | 1H-benzimidazole-1-ethanamine, N,N-diethyl-2-((... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| flunitrazepam | Roipnol, Rohypnol, Narcozep, Darkene | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| fluoxymesterone | Ora-Testryl, Halotestin, Stenox, Android-F, And... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| flurazepam | Dalmane | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| follistatin | activin-binding protein, FST | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| fonturacetam | phenotropil, Carphedone, phenylpiracetam, carph... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| formebolone | 2-formyl-17alpha-methyl-11alpha,17beta-dihydrox... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| formestane | 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazo... | 6000 | Schedule I | Controlled substance: Schedule III; W... | N/A | 1 refs | 2026-01-01 | View details |
| formoterol | eformoterol, formamide, N-(2-hydroxy-5-(1-hydro... | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 2 refs | 2026-01-01 | View details |
| fospropofol | Lusedra | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| fulvestrant | ZM182780, ICI 182,780, ICI-182780, ICI 182780, ... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 2 refs | 2026-01-01 | View details |
| furanyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-c... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| furazabol | furazabolum, 17alpha-methyl-17beta-hydroxyandr... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| furethidine | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperi... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| furfenorex | furfurylmethylamphetamine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | 1 refs | 2026-01-01 | View details |
| furosemide | Lasix | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| galantamine | Razadyne ER, Razadyne, Galantamine HBr, Galanta... | 6000 | N/A | N/A | N/A | 2 refs | 2026-01-01 | View details |
| gamma hydroxybutyric acid | Anetamin, 4-hydroxybutanoic acid, gamma-hydroxy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| gamma-butyrolactone | gamma butyrolactone, GBL, 4-butyrolactone | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ganaxolone | 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| gestrinone | (17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregna... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| glutethimide | Doriden, Dorimide | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| gonadorelin | GNRH, LHRH, luteinizing hormone-releasing facto... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| goralatide | Seraspenide, Ac-SDKP | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| goserelin | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| growth hormone-releasing peptide | GHRP-3, GHRP-4, GHRP-5, GHRP | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | No refs | 2026-01-01 | View details |
| halazepam | Paxipam | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| haloxazolam | Haloxazolamum, Somelin, 10-bromo-11b-(2-fluorop... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| hemp | hemp seed protein, organic hemp protein concent... | 6000 | N/A | Military policy | N/A | 1 refs | 2026-01-01 | View details |
| heptaminol | heptaminol hydrochloride, Corasore, Ginkor Fort... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| heroin | diacetylmorphine, diamorphine hydrochloride, di... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| hexadrone | 6-chloro-androst-4-ene-3-one-17beta-ol, 6-chlor... | 6000 | N/A | WADA S1: AnabolicFDA warning letter: ... | N/A | 2 refs | 2026-01-01 | View details |
| hexedrone | alpha-methylamino-caprophenone, 2-(methylamino)... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| higenamine | (+-)-demethylcoclaurine, Gnetum parvifolium, Ti... | 6000 | N/A | WADA S3: Beta-2 AgonistsFDA warningUn... | N/A | 2 refs | 2026-01-01 | View details |
| histrelin | N/A | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| hordenine | anhaline, p-hydroxy-N,N-dimethylphenethylamine,... | 6000 | N/A | FDA Warning Letter: Does not meet the... | N/A | 1 refs | 2026-01-01 | View details |
| hydrochlorothiazide | Microzide, HCTZ | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| hydrocodone | dihydrocodeinone | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| hydromorphinol | 14-hydroxydihydromorphine, 7,8-dihydro-14-hydro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| hydromorphone | Dilaudid, dihydromorphinone | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| hydroxyamphetamine | hydroxyamfetamine, parahydroxyamphetamine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| hydroxypethidine | Demidone, Oxydolantin, ethyl 4-(3-hydroxyphenyl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| hydroxypropyl betadex | hydroxypropyl BCD, hydroxypropyl-β-cyclodextrin... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| ibogaine | 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| indacaterol | QAB-149, Onbrez | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| indapamide | Lozol | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| indene | 1H-indene | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| ipamorelin | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| isobutyryl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyra... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| isomethadone | isomethadone II, Win 1783, 1,1-diphenyl-1-(dime... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| isometheptene | 5-hepten-2-amine, N,6-dimethyl-, isonyl, octinu... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| isopropylnorsynephrine | Deterenol, isopropyloctopamine, N-isopropylocto... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 2 refs | 2026-01-01 | View details |
| isotonitazene | N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| isovaleryl fentanyl | Isovalerylfentanyl, 3-methyl-N-(1-phenethylpipe... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| ketamine | Ketaset, Special K, Ketalar, K, (±)-2-(2-chloro... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| ketazolam | Contamex, Loftran, Solatran, Anxon | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| ketobemidone | Cliradon | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| kisspeptin | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| kratom | ketum, gratom, kratum, Maeng Da Leaf, drathom, ... | 6000 | N/A | FDA statement: New dietary ingredient... | N/A | 2 refs | 2026-01-01 | View details |
| lacosamide | (R)-2-acetoamido-N-benzyl-3-methoxy-propionamid... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| landogrozumab | anti-myostatin antibody | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| lasmiditan | Reyvow, 2,4,6-trifluoro-N-(6-(1-methylpiperidin... | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| lefetamine | (-)-1-dimethylamino-1,2-diphenylethane, SPA, 1-... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| lemborexant | (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethy... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| lenomorelin | ghrelin human, ghrelin | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| letrozole | CGS20267, CGS-20267, Femara, Fémara, HSDB 7461,... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| leuprorelin | leuprolide | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| levo-alphacetylmethadol | LAAM, levo-alpha-acetylmethadol, levomethadyl a... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| levomethamphetamine | levmetamfetamine, l-methamphetamine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | 1 refs | 2026-01-01 | View details |
| levomethorphan | methorphan, l-methorphan | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| levomoramide | levoramide, (3R)-3-methyl-4-morpholin-4-yl-2,2-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| levophenacylmorphan | (-)-3-hydroxy-N-phenacylmorphinan, benzorphanol | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| levorphanol | Levo-Dromoran | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| levosalbutamol | levalbuterol | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| lisdexamfetamine | Vyvanse | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| lonapegsomatropin | Skytrofa, lonapegsomatropin-tcgd, TRANSCONPEG HGH | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| long R3-IGF-1 | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| loprazolam | N/A | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| lorazepam | Ativan | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| lorcaserin | Belviq | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| lormetazepam | Noctamid | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| luspatercept | Reblozyl | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| luteinizing hormone | LH, luteinising hormone | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| lysergic acid | D-lysergic acid, (8R)-9,10-didehydro-6-methyler... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| lysergic acid amide | D-lysergic acid amide, lysergamide, ergine | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| lysergic acid diethylamide | lysergide, LSD | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| m-hydroxybenzoylecgonine | mOHBE, 3-hydroxybenzoylecgonine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| m-hydroxycocaine | 3'-hydroxybenzoylecgonine methyl ester, 3'-hydr... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| macimorelin | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| marihuana | weed, marijuana, marihuana extract | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| mazindol | Mazanor, Sanorex | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| mebolazine | 17-beta-hydroxy-2alpha,17-dimethyl-5-alpha-andr... | 6000 | N/A | Unapproved drug, FDA warning letter: ... | N/A | 2 refs | 2026-01-01 | View details |
| mebutamate | Capla | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| meclofenoxate | meclophenoxate, centrophenoxine, Analux, dimeth... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| mecloqualone | Nubarene | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| medazepam | Nobrium | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| mefenorex | Doracil, Amexate, Anorexic, Pondinil | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| meldonium | Kvaterin, Quaterin, Q-4224-IOS, mindronate, mil... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| mentabolan | SR 16278, estr-4-ene-3,17-dione, 7alpha-methyl-... | 6000 | N/A | FDA warning letter: synthetic steroid... | N/A | 2 refs | 2026-01-01 | View details |
| mephedrone | Mcat, buphedrone, N,N-dimethyl-cathinone, 3-met... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| mephentermine | mephenterdrinum, mephentermine sulfate, mefente... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| meprobamate | Meprospan, Miltown, Micrainin, Equanil, Equagesic | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| mescaline | 3,4,5-trimethoxyphenethylamine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| mesocarb | N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxad... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| mestanolone | 17alpha-methyl-17beta-hydroxy-5alpha-androstan-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| mesterolone | 1α-methyl-17β-hydroxy-[5α]-androstan-3-one, res... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| meta-fluorofentanyl | N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| meta-fluoroisobutyryl fentanyl | N-(3-fluorophenyl)-N-(1-phenylpiperidin-4-yl)is... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| metazocine | 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexa... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| methadone | Methadose, Amidone, Dolophine | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| methadone-intermediate | 4-cyano-2-dimethylamino-4,4-diphenyl butane | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| methamphetamine | metamfetamine(d-), ICE, Desoxyn, Speed, d-metha... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| methandienone | metaboline, metabolina, 17α-methyl-17β-hydroxya... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methandriol | androdiol, madiol, 17alpha-methyl-3beta,17beta-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methaqualone | Quaalude, Somnafac, Parest, Mandrax, Opitimil | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methasterone | 17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one,... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methcathinone | monomethylpropion, 2-(methylamino)-propiophenon... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methenolone | 1-methyl-17β-hydroxy-5α-androst-1-en-3-one, Pri... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methiopropamine | N-methyl-1-(thiophen-2-yl)propane-2-amine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methohexital | Brevital, methohexitone, methohexitone sodium | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| methoxy polyethylene glycol-epoetin beta | MIRCERA® | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| methoxyacetyl fentanyl | 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-pheny... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methoxydienone | methoxygonadiene, MAX-LMG, Max LMG, 13-beta-Eth... | 6000 | N/A | WADA S1: Anabolic Agents | N/A | 2 refs | 2026-01-01 | View details |
| methoxyphedrine | 4-methoxymethcathinone, methedrone | 6000 | N/A | Controlled substance: Schedule I | N/A | 1 refs | 2026-01-01 | View details |
| methyl-1-testosterone | 17-α-methyl-1-testosterone, 17beta-hydroxy-17al... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methylclostebol | 4-chloro-17alpha-methyl-17beta-hydroxy-androst-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methyldesorphine | MK 57, 3-hydroxy-6,N-dimethyl-4,5-epoxymorphin-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methyldienolone | 17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one,... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methyldihydromorphine | methyl dihydromorphine, morphine, methyldihydro- | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methylephedrine | N-methylephedrine hydrochloride, methylpseudoep... | 6000 | N/A | Federal regulation passed specificall... | N/A | 1 refs | 2026-01-01 | View details |
| methylnaphthidate | 2-piperidineacetic acid, α-2-naphthalenyl-, met... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| methylone | 2,3-methylenedioxymethcathinone, 1-(benzo[d][1,... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| methylphenidate | Tsentedrin, Concerta®, Ritalin®SR, Cotempla®XR-... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| methylphenobarbital | mephobarbital, Mebaral | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| methylstenbolone | 2,17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-on... | 6000 | N/A | WADA S1: Anabolic AgentsFDA warning l... | N/A | 1 refs | 2026-01-01 | View details |
| methylsynephrine | 1-(4-hydroxyphenyl)-2-methylaminopropanol, Oxye... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 1 refs | 2026-01-01 | View details |
| methyltestosterone | 17alpha-methyl-17beta-hydroxyandrost-4-en-3-on... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methylthioninium chloride | methylene blue anhydrous, methylene blue, methy... | 6000 | N/A | Prescription drug | N/A | 1 refs | 2026-01-01 | View details |
| methyltrienolone | 17alpha-methyltrienolone, 17beta-hydroxy-17alph... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| methyprylon | Noludar | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| metodesnitazene | N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimida... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| metolazone | Mykrox®, Zaroxolyn® | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| metonitazene | N,N-diethyl-2-[(4-methoxyphenyl)methyl]-5-nitro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| metopon | dihydro-6-methylmorphinone, methyldihydromorphi... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| mibolerone | 7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-e... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| midazolam | Versed | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| mitochondrial open reading frame of the 12S rRNA-c | MOTS-c, mitochondrial open reading frame of the... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| modafinil | benzhydrylsulfinylacetamide, Sparlon, modafinil... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| molidustat | BAY 85-3934 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| moramide-intermediate | 2-methyl-3-morpholino-1,1-diphenylpropane-carbo... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| morpheridine | TA 1, ethyl 1-(2-morpholin-4-ylethyl)-4-phenylp... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| morphine | morphine methylsulfonate, morphine methylbromid... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| mozavaptan | N/A | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| myo-inositol trispyrophosphate | OXY111A, inositol trispyrophosphate, ITPP cpd, ... | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| myostatin propeptide | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| myrophine | benzylmorphinyl myristate, myrophinium, myristy... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| nabilone | Cesamet, (+)-trans-3-(1,1-dimethylheptyl)-6, 6a... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| nafarelin | LHRH, 6(D-NAL(2)) | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| nalorphine | Nalline | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| nandrolone | 17beta-hydroxyestr-4-en-3-one, 19-nortestostero... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| naphthalene | albocarbon, dezodorator, tar camphor, white tar | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| naphyrone | α-naphyrone, 1-(naphthalen-2-yl)-2-(pyrrolidin-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| nefiracetam | N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| nicocodeine | nicocodine, 6-nicotinoylcodeine, lyopect, nicot... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| nicomorphine | Vilan | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| nikethamide | Anacardone, nicethamide, nicotinic acid diethyl... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| nimetazepam | methylnitrazepam, 1,3-dihydro-1-methyl-7-nitro-... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| nitrazepam | Mogadon | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| nor-NOHA | (2S)-2-amino-4-(((hydroxyamino)iminomethyl)amin... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| noracymethadol | [6-(methylamino)-4,4-diphenylheptan-3-yl] aceta... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| norandrostenediol | 3α, 17β-dihydroxyestr-4-ene, 3alpha,17beta-dihy... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| norandrostenedione | estr-4-en-3,17-dione, estr-4-ene-3,17-dione, No... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| norbenzoylecgonine | NBE, benzoylnorecgonine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| norbolethone | 13beta,17alpha-diethyl-17beta-hydroxygon-4-en-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| norclostebol | 4-chloro-17beta-ol-estr-4-en-3-one, 4-chloro-17... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| norcocaine | n-demethylcocaine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| nordiazepam | nordazepam, dealkylprazepam, Madar, desmethyldi... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| norethandrolone | 17α-ethyl-17β-hydroxyestr-4-en-3-one, Pronabol,... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| norfenefrine | norphenephrine, Novadral, norfenefrine hydrochl... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| norfenfluramine | N/A | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| norfentanyl | N-phenyl-N-(piperidin-4-yl)propionamide | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| norlevorphanol | 3-hydroxymorphinan, morphinan-3-ol | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| normethadone | phenyldimazone | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| normethandrolone | 17α-methyl-19-nortestosterone, Matronal, methyl... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| normorphine | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| noroxymorphone | 7,8-dihydro-14-hydroxynormorphinone, (5alpha)-4... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| norpipanone | Hoechst 10495, Orfenso, 3-hexanone, 4,4-dipheny... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| nortadalafil | N/A | 6000 | N/A | N/A | N/A | 2 refs | 2026-01-01 | View details |
| ocfentanil | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpipe... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| octopamine | 4-(2-amino-1-hydroxyethyl)phenol, Norden, 1-(p-... | 6000 | N/A | FDA Warning Letter: New dietary ingre... | N/A | 1 refs | 2026-01-01 | View details |
| oliceridine | N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| olodaterol | N/A | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| omberacetam | GVS-111, ethyl phenylacetyl-pro-gly, N-phenylac... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| opium | paregoric, opium, raw, opium fluid extract, pow... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| oripavine | N/A | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| ortho-fluoroacryl fentanyl | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ortho-fluorobutyryl fentanyl | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ortho-fluorofentanyl | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ortho-fluorofuranyl fentanyl | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| ortho-fluoroisobutyryl fentanyl | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ortho-methyl acetylfentanyl | 2-methylacetylfentanyl, N-(2-methylphenyl)-N-(1... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| ortho-methyl methoxyacetylfentanyl | 2-methyl methoxyacetyl fentanyl, 2-methoxy-N-(2... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| osilodrostat | Isturisa | 6000 | N/A | WADA S1: Anabolic AgentsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| ospemifene | FC-1271a, CCRIS 9205, 2-(p-((Z)-4-chloro-1,2-di... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| oxabolone | 4,17beta-dihydroxyestr-4-en-3-one, 4,17β-dihydr... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| oxandrolone | 17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-o... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| oxazepam | Serenid-D, Serax | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| oxazolam | Convertal, Serenal | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| oxiracetam | 4-hydroxy-2-oxo-pyrrolidinacetamide | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| oxycodone | OxyContin, Roxicodone, Endocet, Percocet, Roxicet | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| oxyguno | 4-chloro-17alpha-methyl-17beta-hydroxy-androst-... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| oxymesterone | 17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| oxymetholone | Anadrol-50, 17β-Hydroxy-2-hydroxymethylidene-17... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| oxymorphone | Numorphan | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| p-hydroxybenzoylecgonine | pOHBE, 4-hydroxybenzoylecgonine | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| p-hydroxycocaine | 4'-hydroxybenzoylecgonine methyl ester, 4'-hydr... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| para-chloroisobutyryl fentanyl | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-fluoro furanyl fentanyl | N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-fluorobutyryl fentanyl | N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-fluorofentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piper... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-methoxybutyryl fentanyl | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-y... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-methoxyfuranyl fentanyl | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-y... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| para-methoxymethamphetamine | PMMA, 1-(4-methoxyphenyl)-N-methylpropan-2-amine | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| para-methylcyclopropyl fentanyl | N-(4-methylphenyl)-N-(1-phenylpiperidin-4-yl)cy... | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
| para-methylfentanyl | 4-methylfentanyl, N-(4-methylphenyl)-N-(1-phene... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| parahexyl | Synhexyl, 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| paraldehyde | Paral | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| peginesatide | hematide | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| pemoline | Cylert | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| pentazocine | Talacen, Talwin NX, Talwin Compound, Talwin | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| pentedrone | 4-methylbuphedrone, 2-(methylamino)-1-phenylpen... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| pentetrazol | leptazole, metrazole, PTZ, Corazol, Korazole, K... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| pentobarbital | Nembutal | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pentylone | propylone, bk-DMBDB, 1-(1,3-benzodioxol-5-yl)-2... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| perampanel | Fycompa, 2-(2-oxo-l-phenyl-5-pyridin-2-yl-l,2-d... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| pethidine | meperidine, Demerol, Mepergan | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pethidine-intermediate-A | 4-cyano-1-methyl-4-phenylpiperidine, meperedine... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pethidine-intermediate-B | ethyl-4-phenylpiperidine-4-carboxylate, normepe... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pethidine-intermediate-C | 1-methyl-4-phenylpiperidine-4-carboxylic acid, ... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| petrichloral | Pentaerythritol chloral, Periclor | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| peyote | Lophophora williamsii Lemaire | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenadoxone | 6-morpholino-4,4-diphenyl-3-heptanone, 4,4-diph... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenampromide | N-(1-methyl-2-piperidinoethyl)propionanilide, f... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenazocine | Prinadol, Narphen | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| phencyclidine | Semylan, 1-(1-phenylcyclohexyl)piperidine, PCP | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| phendimetrazine | Prelu-2, Statobex, Melfiat, Bontril, Plegine | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| phenibut | 4-amino-3-phenylbutyric acid hydrochloride, phe... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 2 refs | 2026-01-01 | View details |
| phenmetrazine | Preludin | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| phenobarbital | Bellergal-S, Luminal | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| phenomorphan | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenoperidine | Operidine, Lealgin | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenpromethamine | 1-methylamino-2-phenylpropane, N,β-dimethylphen... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| phentermine | Phentrol, Lonamin, Fastin, normephentermine, ph... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| phenyl fentanyl | benzoyl fentanyl, N-(1-phenethylpiperidin-4-yl)... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| phenylacetone | P2P, benzyl methyl ketone, methyl benzyl ketone... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pholcodine | Lantuss, Pholcolin, Adaphol, Codisol, Copholco | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| picamilon | 4-(pyridine-3-carbonylamino) butanoic acid, pik... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 2 refs | 2026-01-01 | View details |
| piminodine | N/A | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pinazepam | Domar | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| pipradrol | Stimolag Fortis, Detaril | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| piracetam | 2-oxo-pyrrolidin-1-ylacetamide, 2-pyrrolidone-N... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| piritramide | Piridolan | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| poppy straw | concentrate of poppy straw, CPS, poppy heads, o... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| pralmorelin | GHRP-2, growth hormone-releasing peptide-2 | 6000 | N/A | WADA S2: HormonesUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| pramiracetam | 1-pyrrolidineacetamide, N-(2-(bis(1-methylethyl... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| prazepam | Centrax | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| pregabalin | (S)-3-(aminomethyl)-5-methylhexanoic acid, Lyrica | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| pregnenolone | Pregnetan, 5-pregnen-3β-ol-20-one, 5 pregnen 3 ... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| prenylamine | Difril, Falliocor, Synadrin, prenylaminum, Vale... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| probenecid | Probalan | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| procaterol | procaterol hydrochloride hydrate, procaterol hy... | 6000 | N/A | WADA S3: Beta-2 AgonistsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| proheptazine | dimepheprimine, 1,3-dimethyl-4-phenyl-4-propion... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| prolintane | prolintano, prolintan, Promotil, Villescon, Cat... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| properidine | isopropyl 1-methyl-4-phenylisonipecotate, gevel... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| propiram | Algeril | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| prostanozol | 17β-hydroxy-5α-androstano[3,2-c]pyrazole, 17β-[... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| protonitazene | N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-b... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| pseudoephedrine | pseudoephedrine HCl, (1S,2S)-2-(methylamino)-1-... | 6000 | N/A | Over-the-counter (OTC) drug | N/A | 2 refs | 2026-01-01 | View details |
| psilocybin | N/A | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| psilocyn | psilocin | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| pyrovalerone | Centroton, Thymergix | 6000 | Schedule V | Controlled substance: Schedule V | N/A | No refs | 2026-01-01 | View details |
| pyrrole | 1h-pyrrole, imidole, azole, 1-aza-2,4-cyclopent... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| quazepam | Doral | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| quinbolone | androsta-1,4-dien-3-one, 17-(1-cyclopenten-1-yl... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| quinethazone | Hydromox | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| racemethorphan | DL-methorphan, 3-methoxy-17-methylmorphinan, ra... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| racemoramide | dimorlin, DL-moramide | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| racemorphan | Dromoran | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| ractopamine | N/A | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| raloxifene | LY-139481, LY 139481, LY-156758, (2-(4-Hydroxyp... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| reldesemtiv | CK-2127107 | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| remifentanil | Ultiva | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| remimazolam | methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | 1 refs | 2026-01-01 | View details |
| reproterol | 7-(3-((beta,3,5-trihydroxyphenethyl)amino)propy... | 6000 | N/A | WADA S3: Beta-2 AgonistsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| rismorelin | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| roxadustat | FG-4592 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| salbutamol | albuterol | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| salmeterol | Serevent | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| secobarbital | Quinalbarbitone, Tuinal, Seconal | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| semax | N/A | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| serdexmethylphenidate | 3-[[[(1S)-1-carboxy-2-hydroxyethyl]-amino]carbo... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | 1 refs | 2026-01-01 | View details |
| sermorelin | Geref | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| sibutramine | sibutraminum, mono-desmethylsibutramine, N-1-(1... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | 1 refs | 2026-01-01 | View details |
| sildenafil | Viagra | 6000 | N/A | Prescription drug | N/A | 1 refs | 2026-01-01 | View details |
| sodium tetrachloroaurate | sodium tetrachloroaurate (3+), gold sodium chlo... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| solriamfetol | benzenepropanol, beta-amino-, carbamate (ester)... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | 1 refs | 2026-01-01 | View details |
| somapacitan | somapacitan-geco | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| somatorelin | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| somatrogon | Ngenla, NGENLA | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| sotatercept | ACE-011 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| spironolactone | Verospiron, spiro(17H-cyclopenta(a)phenauthrene... | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| stamulumab | Myo-29 | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| stanozolol | 17-beta-hydroxy-17-alpha-methylandrostano(3,2-c... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| stenbolone | 17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one, 1... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| strychnine | strychinos, strychnine nitrate, estricnina, str... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| sufentanil | Sufenta | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| sulbutiamine | sulbutiaminum, Bis(1-(4-amino-2-methyl-5-pyrimi... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| sulfondiethylmethane | tetronal, 3,3-bis(ethylsulfonyl)pentane | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| sulfonethylmethane | N/A | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| sulfonmethane | trional, methylsulfonal, 2,2-bis(ethylsulfonyl)... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| sunifiram | 1-benzoyl-4-propanoylpiperazine, piperazine, 1-... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| suvorexant | [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| synthetic cannabinoids | pyrrolo-benzoxazine, cannabinoid derivative, in... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| tabimorelin | D-phenylalaninamide, N-((2E)-5-amino-5-methyl-1... | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| tadalafil | Cialis | 6000 | N/A | Prescription drug | N/A | 1 refs | 2026-01-01 | View details |
| talbutal | Lotusate | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| tamoxifen | ICI-47699, ICI-46,474, Crisafeno, ICI 46,474, H... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| tapentadol | N/A | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| tauroursodeoxycholic acid | TUDCA, tauroursodeoxycholic acid (TUDCA), tuaro... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| temazepam | Restoril | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| terbutaline | terbutaline sulfate | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| tesamorelin | egrifta | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| tesofensine | NS-2330 | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| testolactone | 13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| testosterone | testosterone phenylpropionate, testosterone ace... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| tetracosactide | cosyntropin | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| tetrahydrocannabinols | delta-9-THC, 6 trans tetrahydrocannabinol, delt... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| tetrahydrofuranyl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydr... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| tetrahydrogestrinone | 17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-tr... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| tetrazepam | Myolastan, Musaril | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| thebacon | acetylhydrocodone, Acedicon, Thebacetyl | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| thebaine | paramorphine, codeine methyl enol ether, 3-O-me... | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| thiafentanil | Thianil | 6000 | N/A | Controlled substance: Schedule II | N/A | No refs | 2026-01-01 | View details |
| thiamylal | Surital | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| thiazolidene | tetrahydrothiazole, 1,3-thiazolidine, 1-thia-3-... | 6000 | N/A | Use or misuse prohibited under DoDI 1... | N/A | No refs | 2026-01-01 | View details |
| thiofentanyl | N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]pr... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| thiofuranyl fentanyl | N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| thiomesterone | 1,7-bis(acetylthio)-17β-hydroxy-17α-methyl-andr... | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| thiopental | Pentothal | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| thymosin beta 4 | thymosin-β4, Timbetasin, Tβ4 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| tianeptine | Tianna White, Tianna Red, tianeptine sodium pow... | 6000 | N/A | FDA statement: Not a dietary ingredie... | N/A | 1 refs | 2026-01-01 | View details |
| tibolone | 17-hydroxy-7α-methyl-19-nor-17α-pregn-5(10)-en-... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| tiletamine | Telazol, 2-(ethylamino)-2-(2-thienyl)-cyclohexa... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| tilidine | Lak, Kitadol, Tilsa, Tilidate, Valoron | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| tirasemtiv | CK-2017357 | 6000 | N/A | N/A | N/A | 1 refs | 2026-01-01 | View details |
| tolvaptan | Jynarque | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| torasemide | Demadex, torsemide | 6000 | N/A | WADA S5: Diuretics and Masking Agents | N/A | 1 refs | 2026-01-01 | View details |
| toremifene | Fareston, GTx 006, toremifeno, NK 622, toremife... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| tramadol | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cy... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| trenbolone | 17 beta-acetoxyestra-4,9,11-trien-3-one, trenbo... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| trestolone | 19-nor-methyltestosterone, MENT, 7α-methyl-19-n... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| tretoquinol | trimethoquinol, trimetoquinol, tretoquinol, (+)- | 6000 | N/A | WADA S3: Beta-2 AgonistsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| triacetyluridine | uridine triacetate, TAU, Xuriden | 6000 | N/A | Prescription drug | N/A | 1 refs | 2026-01-01 | View details |
| triamterene | 2,4,7-triamino-6-phenylpteridine, 6-phenylpteri... | 6000 | N/A | WADA S5: Diuretics and Masking Agents... | N/A | 1 refs | 2026-01-01 | View details |
| triazolam | Halcion | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| trimeperidine | Promedolum | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| trimetazidine | trimetazidine hydrochloride, Idaptan, Vasorel, ... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| triptorelin | Arvekap, Triptodur | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| tuaminoheptane | tuaminoheptano, 2-aminoheptane, Rineptyl, hepti... | 6000 | N/A | Unapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| tulobuterol | alpha-((tert-butylamino)methyl)-O-chlorobenzyl ... | 6000 | N/A | WADA S3: Beta-2 AgonistsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| unifiram | DM-232, pyrrolo(1,2-A)pyrazin-6(2H)-one, 2-((4-... | 6000 | N/A | WADA S4: Hormone and Metabolic Modula... | N/A | 1 refs | 2026-01-01 | View details |
| vadadustat | AKB-6548 | 6000 | N/A | WADA S2: Peptide Hormones, Growth Fac... | N/A | 1 refs | 2026-01-01 | View details |
| valeryl fentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| vilanterol | GW-642444X | 6000 | N/A | WADA S3: Beta-2 AgonistsPrescription ... | N/A | 1 refs | 2026-01-01 | View details |
| vinbarbital | Delvinal, vinbarbitone | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| vinpocetine | Vinpocetine Oral Grade, ethyl apovincamin-22-oa... | 6000 | N/A | FDA statement: Synthetic substance th... | N/A | 2 refs | 2026-01-01 | View details |
| vosilasarm | 2-chloro-4-((1R,2S)-1-(5-(4-cyanophenyl)-1,3,4-... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved dr... | N/A | 2 refs | 2026-01-01 | View details |
| xenon | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| xipamide | N/A | 6000 | N/A | N/A | N/A | No refs | 2026-01-01 | View details |
| zaleplon | Sonata | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| zeranol | (3S,7R)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| zilpaterol | imidazo(4,5,1-jk)(1)benzazepin-2(1H)-one, 4,5,6... | 6000 | N/A | WADA S1: Anabolic AgentsUnapproved drug | N/A | 1 refs | 2026-01-01 | View details |
| zipeprol | 1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperaz... | 6000 | Schedule I | Controlled substance: Schedule I | N/A | No refs | 2026-01-01 | View details |
| zolazepam | 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylp... | 6000 | Schedule I | Controlled substance: Schedule III | N/A | No refs | 2026-01-01 | View details |
| zolpidem | Ambien, Stilnoct, Ivadal, N,N-dimethyl-2-[6-met... | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| zopiclone | Lunesta, Imovane, Zimovane | 6000 | Schedule I | Controlled substance: Schedule IV | N/A | No refs | 2026-01-01 | View details |
| zuranolone | Zurzuvae | 6000 | Schedule I | N/A | N/A | No refs | 2026-01-01 | View details |
Showing 877 substances
Table Features:
- Sortable columns: Click any column header to sort the table
- Filtering: Use the filter controls above to narrow down results
- Search: Use your browser's search function (Ctrl/Cmd+F) to find specific substances
- Details: Click 'View details' for comprehensive information about each substance
Note: Some content may be truncated in this table view. Click 'View details' for complete information.